Breast cancer, version 3.2013

Richard L. Theriault, Robert W. Carlson, Craig Allred, Benjamin O. Anderson, Harold J. Burstein, Stephen B. Edge, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford A. Hudis, Steven J. Isakoff, Britt Marie E. Ljung, David A. Mankoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Lori J. Pierce & 10 others Elizabeth C. Reed, Lee Schwartzberg, Mary Lou Smith, Hatem Soliman, George Somlo, John H. Ward, Antonio C. Wolff, Richard Zellars, Dorothy A. Shead, Rashmi Kumar

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

These NCCN Guidelines Insights highlight the important updates specific to the management of HER2-positive metastatic breast cancer in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer. These include new first-line and subsequent therapy options for patients with HER2-positive metastatic breast cancer.

Original languageEnglish (US)
Pages (from-to)753-761
Number of pages9
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume11
Issue number7
DOIs
StatePublished - Jul 1 2013

Fingerprint

Breast Neoplasms
Practice Guidelines
Guidelines
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Theriault, R. L., Carlson, R. W., Allred, C., Anderson, B. O., Burstein, H. J., Edge, S. B., ... Kumar, R. (2013). Breast cancer, version 3.2013. JNCCN Journal of the National Comprehensive Cancer Network, 11(7), 753-761. https://doi.org/10.6004/jnccn.2013.0098

Breast cancer, version 3.2013. / Theriault, Richard L.; Carlson, Robert W.; Allred, Craig; Anderson, Benjamin O.; Burstein, Harold J.; Edge, Stephen B.; Farrar, William B.; Forero, Andres; Giordano, Sharon Hermes; Goldstein, Lori J.; Gradishar, William J.; Hayes, Daniel F.; Hudis, Clifford A.; Isakoff, Steven J.; Ljung, Britt Marie E.; Mankoff, David A.; Marcom, P. Kelly; Mayer, Ingrid A.; McCormick, Beryl; Pierce, Lori J.; Reed, Elizabeth C.; Schwartzberg, Lee; Smith, Mary Lou; Soliman, Hatem; Somlo, George; Ward, John H.; Wolff, Antonio C.; Zellars, Richard; Shead, Dorothy A.; Kumar, Rashmi.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 11, No. 7, 01.07.2013, p. 753-761.

Research output: Contribution to journalArticle

Theriault, RL, Carlson, RW, Allred, C, Anderson, BO, Burstein, HJ, Edge, SB, Farrar, WB, Forero, A, Giordano, SH, Goldstein, LJ, Gradishar, WJ, Hayes, DF, Hudis, CA, Isakoff, SJ, Ljung, BME, Mankoff, DA, Marcom, PK, Mayer, IA, McCormick, B, Pierce, LJ, Reed, EC, Schwartzberg, L, Smith, ML, Soliman, H, Somlo, G, Ward, JH, Wolff, AC, Zellars, R, Shead, DA & Kumar, R 2013, 'Breast cancer, version 3.2013', JNCCN Journal of the National Comprehensive Cancer Network, vol. 11, no. 7, pp. 753-761. https://doi.org/10.6004/jnccn.2013.0098
Theriault RL, Carlson RW, Allred C, Anderson BO, Burstein HJ, Edge SB et al. Breast cancer, version 3.2013. JNCCN Journal of the National Comprehensive Cancer Network. 2013 Jul 1;11(7):753-761. https://doi.org/10.6004/jnccn.2013.0098
Theriault, Richard L. ; Carlson, Robert W. ; Allred, Craig ; Anderson, Benjamin O. ; Burstein, Harold J. ; Edge, Stephen B. ; Farrar, William B. ; Forero, Andres ; Giordano, Sharon Hermes ; Goldstein, Lori J. ; Gradishar, William J. ; Hayes, Daniel F. ; Hudis, Clifford A. ; Isakoff, Steven J. ; Ljung, Britt Marie E. ; Mankoff, David A. ; Marcom, P. Kelly ; Mayer, Ingrid A. ; McCormick, Beryl ; Pierce, Lori J. ; Reed, Elizabeth C. ; Schwartzberg, Lee ; Smith, Mary Lou ; Soliman, Hatem ; Somlo, George ; Ward, John H. ; Wolff, Antonio C. ; Zellars, Richard ; Shead, Dorothy A. ; Kumar, Rashmi. / Breast cancer, version 3.2013. In: JNCCN Journal of the National Comprehensive Cancer Network. 2013 ; Vol. 11, No. 7. pp. 753-761.
@article{710dc5982bfd4658be472474c62a6bf7,
title = "Breast cancer, version 3.2013",
abstract = "These NCCN Guidelines Insights highlight the important updates specific to the management of HER2-positive metastatic breast cancer in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer. These include new first-line and subsequent therapy options for patients with HER2-positive metastatic breast cancer.",
author = "Theriault, {Richard L.} and Carlson, {Robert W.} and Craig Allred and Anderson, {Benjamin O.} and Burstein, {Harold J.} and Edge, {Stephen B.} and Farrar, {William B.} and Andres Forero and Giordano, {Sharon Hermes} and Goldstein, {Lori J.} and Gradishar, {William J.} and Hayes, {Daniel F.} and Hudis, {Clifford A.} and Isakoff, {Steven J.} and Ljung, {Britt Marie E.} and Mankoff, {David A.} and Marcom, {P. Kelly} and Mayer, {Ingrid A.} and Beryl McCormick and Pierce, {Lori J.} and Reed, {Elizabeth C.} and Lee Schwartzberg and Smith, {Mary Lou} and Hatem Soliman and George Somlo and Ward, {John H.} and Wolff, {Antonio C.} and Richard Zellars and Shead, {Dorothy A.} and Rashmi Kumar",
year = "2013",
month = "7",
day = "1",
doi = "10.6004/jnccn.2013.0098",
language = "English (US)",
volume = "11",
pages = "753--761",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",

}

TY - JOUR

T1 - Breast cancer, version 3.2013

AU - Theriault, Richard L.

AU - Carlson, Robert W.

AU - Allred, Craig

AU - Anderson, Benjamin O.

AU - Burstein, Harold J.

AU - Edge, Stephen B.

AU - Farrar, William B.

AU - Forero, Andres

AU - Giordano, Sharon Hermes

AU - Goldstein, Lori J.

AU - Gradishar, William J.

AU - Hayes, Daniel F.

AU - Hudis, Clifford A.

AU - Isakoff, Steven J.

AU - Ljung, Britt Marie E.

AU - Mankoff, David A.

AU - Marcom, P. Kelly

AU - Mayer, Ingrid A.

AU - McCormick, Beryl

AU - Pierce, Lori J.

AU - Reed, Elizabeth C.

AU - Schwartzberg, Lee

AU - Smith, Mary Lou

AU - Soliman, Hatem

AU - Somlo, George

AU - Ward, John H.

AU - Wolff, Antonio C.

AU - Zellars, Richard

AU - Shead, Dorothy A.

AU - Kumar, Rashmi

PY - 2013/7/1

Y1 - 2013/7/1

N2 - These NCCN Guidelines Insights highlight the important updates specific to the management of HER2-positive metastatic breast cancer in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer. These include new first-line and subsequent therapy options for patients with HER2-positive metastatic breast cancer.

AB - These NCCN Guidelines Insights highlight the important updates specific to the management of HER2-positive metastatic breast cancer in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer. These include new first-line and subsequent therapy options for patients with HER2-positive metastatic breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=84880964487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880964487&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2013.0098

DO - 10.6004/jnccn.2013.0098

M3 - Article

VL - 11

SP - 753

EP - 761

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 7

ER -